Patents by Inventor Naruto Katsuragi

Naruto Katsuragi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY AGAINST PEPTIDE ENCODED BY EXON-21 OF PERIOSTIN AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATION-ASSOCIATED DISEASES CONTAINING THE SAME
    Publication number: 20190106484
    Abstract: The present invention provides a drug for preventing or treating inflammation-associated diseases in which a periostin isoform having cell adhesion activity is involved, and also provides an inhibitor of a periostin isoform having cell adhesion activity.
    Type: Application
    Filed: October 23, 2018
    Publication date: April 11, 2019
    Applicant: OSAKA UNIVERSITY
    Inventors: Yoshiaki TANIYAMA, Ryuichi MORISHITA, Junya AZUMA, Fumihiro SANADA, Naruto KATSURAGI
  • Antibody against peptide encoded by Exon-21 of periostin and pharmaceutical composition for preventing or treating inflammation-associated diseases containing the same
    Patent number: 10227396
    Abstract: The present invention provides a drug for preventing or treating inflammation-associated diseases in which a periostin isoform having cell adhesion activity is involved, and also provides an inhibitor of a periostin isoform having cell adhesion activity.
    Type: Grant
    Filed: March 6, 2014
    Date of Patent: March 12, 2019
    Assignee: OSAKA UNIVERSITY
    Inventors: Yoshiaki Taniyama, Ryuichi Morishita, Junya Azuma, Fumihiro Sanada, Naruto Katsuragi
  • ANTIBODY TO PEPTIDE ENCODED BY Exon-21 OF PERIOSTIN, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF INFLAMMATORY DISEASE CONTAINING SAID ANTIBODY
    Publication number: 20160108109
    Abstract: The present invention provides a drug for preventing or treating inflammation-associated diseases in which a periostin isoform having cell adhesion activity is involved, and also provides an inhibitor of a periostin isoform having cell adhesion activity.
    Type: Application
    Filed: March 6, 2014
    Publication date: April 21, 2016
    Inventors: Yoshiaki TANIYAMA, Ryuichi MORISHITA, Junya AZUMA, Fumihiro SANADA, Naruto KATSURAGI
  • Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved
    Patent number: 8372957
    Abstract: The present invention provides an antibody against a periostin isoform having anti-cell adhesive activity, especially an anti-periostin antibody having the ability to neutralize anti-cell adhesive properties, as well as a prophylactic or therapeutic agent for periostin-related diseases comprising the antibody. The present invention also provides methods for detecting and quantifying the periostin isoform in a sample by using the antibody, as well as a method for diagnosing periostin-related diseases comprising measuring the amount of the periostin isoform by the detection or quantification method.
    Type: Grant
    Filed: August 4, 2011
    Date of Patent: February 12, 2013
    Assignees: Daiichi Sankyo Company, Limited, Osaka University
    Inventors: Yoshiaki Taniyama, Ryuichi Morishita, Naruto Katsuragi
  • ANTIBODY AGAINST PERIOSTIN, AND A PHARMACEUTICAL COMPOSITION COMPRISING IT FOR PREVENTING OR TREATING A DISEASE IN WHICH PERIOSTIN IS INVOLVED
    Publication number: 20120058572
    Abstract: The present invention provides an antibody against a periostin isoform having anti-cell adhesive activity, especially an anti-periostin antibody having the ability to neutralize anti-cell adhesive properties, as well as a prophylactic or therapeutic agent for periostin-related diseases comprising the antibody. The present invention also provides methods for detecting and quantifying the periostin isoform in a sample by using the antibody, as well as a method for diagnosing periostin-related diseases comprising measuring the amount of the periostin isoform by the detection or quantification method.
    Type: Application
    Filed: August 4, 2011
    Publication date: March 8, 2012
    Applicants: Osaka University, Daiichi Sankyo Company, Limited `
    Inventors: Yoshiaki TANIYAMA, Ryuichi Morishita, Naruto Katsuragi
  • Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved
    Patent number: 8017119
    Abstract: The present invention provides an antibody against a periostin isoform having anti-cell adhesive activity, especially an anti-periostin antibody having the ability to neutralize anti-cell adhesive properties, as well as a prophylactic or therapeutic agent for periostin-related diseases comprising the antibody. The present invention also provides methods for detecting and quantifying the periostin isoform in a sample by using the antibody, as well as a method for diagnosing periostin-related diseases comprising measuring the amount of the periostin isoform by the detection or quantification method.
    Type: Grant
    Filed: June 26, 2008
    Date of Patent: September 13, 2011
    Assignees: Daiichi Sankyo Company, Ltd., Osaka University
    Inventors: Yoshiaki Taniyama, Ryuichi Morishita, Naruto Katsuragi
  • Remedies for heart failure
    Patent number: 7816511
    Abstract: The present invention provides methods for screening drugs inhibiting the expression of OSF-2 gene or the production or function of the protein encoded thereby and therapeutic agents for heart failure having such effects. Useful methods for diagnosing heart failure can be provided by monitoring the expression or variation of said gene or the production of the protein encoded thereby. The present invention also provides transgenic animals with forced expression of OSF-2 gene and methods for studying changes in gene expression or protein production or the functions of various genes or proteins with the progress of the pathology of heart failure using them and novel therapeutic agents for heart failure.
    Type: Grant
    Filed: July 16, 2003
    Date of Patent: October 19, 2010
    Assignee: Asubio Pharma Co., Ltd.
    Inventors: Kayoko Kawashima, Naruto Katsuragi, Keijiro Sugimura, Mayumi Furuya, Ryuichi Morishita
  • Antibody Against Periostin, and a Pharmaceutical Composition comprising it for Preventing or Treating a Disease in which Periostin is Involved
    Publication number: 20090074788
    Abstract: The present invention provides an antibody against a periostin isoform having anti-cell adhesive activity, especially an anti-periostin antibody having the ability to neutralize anti-cell adhesive properties, as well as a prophylactic or therapeutic agent for periostin-related diseases comprising the antibody. The present invention also provides methods for detecting and quantifying the periostin isoform in a sample by using the antibody, as well as a method for diagnosing periostin-related diseases comprising measuring the amount of the periostin isoform by the detection or quantification method.
    Type: Application
    Filed: June 26, 2008
    Publication date: March 19, 2009
    Applicants: Asubio Pharma Co., Ltd., Osaka University
    Inventors: Yoshiaki Taniyama, Ryuichi Morishita, Naruto Katsuragi
  • Remedies for heart failure
    Publication number: 20040029827
    Abstract: The present invention provides methods for screening drugs inhibiting the expression of OSF-2 gene or the production or function of the protein encoded thereby and therapeutic agents for heart failure having such effects. Useful methods for diagnosing heart failure can be provided by monitoring the expression or variation of said gene or the production of the protein encoded thereby. The present invention also provides transgenic animals with forced expression of OSF-2 gene and methods for studying changes in gene expression or protein production or the functions of various genes or proteins with the progress of the pathology of heart failure using them and novel therapeutic agents for heart failure.
    Type: Application
    Filed: July 16, 2003
    Publication date: February 12, 2004
    Applicants: DAIICHI SUNTORY PHARMA CO., LTD., DAIICHI SUNTORY BIOMEDICAL RESEARCH, LTD.
    Inventors: Kayoko Kawashima, Naruto Katsuragi, Keijiro Sugimura, Mayumi Furuya, Ryuichi Morishita